Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Santens

Showing results (111-120 of 123) with videos related to

Pageof 13
Sort By:
Neurobiology of Aging|January 11, 2017
Investigating the role of ALS genes CHCHD10 and TUBA4A in Belgian FTD-ALS spectrum patientsFederica Perrone, Hung Phuoc Nguyen, Sara Van Mossevelde, et al.
Nature|July 25, 2006
Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21Marc Cruts, Ilse Gijselinck, Julie van der Zee, et al.
Acta Neuropathologica Communications|November 12, 2015
Investigating the role of filamin C in Belgian patients with frontotemporal dementia linked to GRN deficiency in FTLD-TDP brainsJonathan Janssens, Stéphanie Philtjens, Gernot Kleinberger, et al.
Human Mutation|March 9, 2007
Mutations other than null mutations producing a pathogenic loss of progranulin in frontotemporal dementiaJulie van der Zee, Isabelle Le Ber, Sebastian Maurer-Stroh, et al.
Neurobiology of Aging|April 14, 2018
Clinical variability and onset age modifiers in an extended Belgian GRN founder familyEline Wauters, Sara Van Mossevelde, Kristel Sleegers, et al.
JAMA Neurology|February 14, 2017
Clinical Evidence of Disease Anticipation in Families Segregating a C9orf72 Repeat ExpansionSara Van Mossevelde, Julie van der Zee, Ilse Gijselinck, et al.
Archives of Neurology|October 10, 2007
Alzheimer and Parkinson diagnoses in progranulin null mutation carriers in an extended founder familyNathalie Brouwers, Karen Nuytemans, Julie van der Zee, et al.
JAMA Neurology|January 23, 2013
Distinct clinical characteristics of C9orf72 expansion carriers compared with GRN, MAPT, and nonmutation carriers in a Flanders-Belgian FTLD cohortTim Van Langenhove, Julie van der Zee, Ilse Gijselinck, et al.
Acta Neuropathologica|March 16, 2019
Loss of DPP6 in neurodegenerative dementia: a genetic player in the dysfunction of neuronal excitabilityRita Cacace, Bavo Heeman, Sara Van Mossevelde, et al.
The Lancet. Neurology|December 14, 2011
A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification studyIlse Gijselinck, Tim Van Langenhove, Julie van der Zee, et al.
Pageof 13

Showing results (111-120 of 123) with videos related to

Sort By:
Pageof 13
Neurobiology of Aging|January 11, 2017
Investigating the role of ALS genes CHCHD10 and TUBA4A in Belgian FTD-ALS spectrum patientsFederica Perrone, Hung Phuoc Nguyen, Sara Van Mossevelde, et al.
Nature|July 25, 2006
Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21Marc Cruts, Ilse Gijselinck, Julie van der Zee, et al.
Acta Neuropathologica Communications|November 12, 2015
Investigating the role of filamin C in Belgian patients with frontotemporal dementia linked to GRN deficiency in FTLD-TDP brainsJonathan Janssens, Stéphanie Philtjens, Gernot Kleinberger, et al.
Human Mutation|March 9, 2007
Mutations other than null mutations producing a pathogenic loss of progranulin in frontotemporal dementiaJulie van der Zee, Isabelle Le Ber, Sebastian Maurer-Stroh, et al.
Neurobiology of Aging|April 14, 2018
Clinical variability and onset age modifiers in an extended Belgian GRN founder familyEline Wauters, Sara Van Mossevelde, Kristel Sleegers, et al.
JAMA Neurology|February 14, 2017
Clinical Evidence of Disease Anticipation in Families Segregating a C9orf72 Repeat ExpansionSara Van Mossevelde, Julie van der Zee, Ilse Gijselinck, et al.
Archives of Neurology|October 10, 2007
Alzheimer and Parkinson diagnoses in progranulin null mutation carriers in an extended founder familyNathalie Brouwers, Karen Nuytemans, Julie van der Zee, et al.
JAMA Neurology|January 23, 2013
Distinct clinical characteristics of C9orf72 expansion carriers compared with GRN, MAPT, and nonmutation carriers in a Flanders-Belgian FTLD cohortTim Van Langenhove, Julie van der Zee, Ilse Gijselinck, et al.
Acta Neuropathologica|March 16, 2019
Loss of DPP6 in neurodegenerative dementia: a genetic player in the dysfunction of neuronal excitabilityRita Cacace, Bavo Heeman, Sara Van Mossevelde, et al.
The Lancet. Neurology|December 14, 2011
A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification studyIlse Gijselinck, Tim Van Langenhove, Julie van der Zee, et al.
Pageof 13